Several new concepts have originated in the international debate on drug policy interventions in recent years. ‘Open drug scenes’ is one of these concepts. Findings, predominantly qualitative, from 9 uropean cities are presented. From a contrast analysis, the concept of open drug scenes is elaborated along three dimensions (visibility, size and site), resulting in a typology of local drug scenes (concentrated open scenes, dispersed open scenes and hidden scenes). This typology is then confronted with local definitions and perceptions, as well as with major issues in the local policy debate on drug problems. As a next step, two contrasting strategies to control drug scenes are presented. These strategies are evaluated in reference to our typology dimensions as well as to the local drug policy key issues. Finally, some conclusions are drawn about the relationship between urban drug policies and the visibility of drug problems.

Keywords:
Drug policy, Law enforcement, Harm reduction, Cross-national, qualitative comparison
This content is only available via PDF.
© 1995 S. Karger AG, Basel
1995
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.